American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

Hang Seng Index forecast and top gainers of 2025 revealed

by admin August 5, 2025
August 5, 2025
Hang Seng Index forecast and top gainers of 2025 revealed

The Hang Seng Index moved sideways as investors watched the ongoing trade negotiations between the United States and China. It was trading at H$24,800 on Tuesday, marginally higher than this week’s low of $24,680. 

Hang Seng Index technical analysis

The daily chart shows that the Hang Seng Index has been in a strong uptrend in the past few months. It jumped from a low of $18,650 in January to the current $24,800, a 32% jump.

The index has remained above the 50-day Exponential Moving Average (EMA), a sign that bulls remain in control. It is also hovering at the crucial level at $24,870, a significant level since it was the highest swing on March 19th this year.

The Hang Seng  Index has formed an ascending channel and is now slightly above the lower side. Therefore, the most likely scenario is where the index rebound and possibly hits the resistance level at $25,000. A move above that level will signal further gains, potentially reaching the year-to-date high of $25,705. 

Hang Seng Index chart | Source: TradingView

China and US talks

The main catalyst for the Hang Seng Index is the China-US trade talks that will reduce the ongoing trade war. Most market participants hope that the two sides will reach an agreement soon. 

A key issue has been demand by the United States for China to halt Russian oil and gas purchases over the ongoing war in Ukraine.

Still, based on the recent trade agreements between the US and other countries, there are signs that the two will reach a deal soon. Such a deal will likely see China make more purchases of US goods, while leaving a 15% tariff in place.

The Hang Seng Index is widely seen as a proxy for China’s equity market. However, a close look at its constituents shows that many of them, including big names like Tencent, ICBC, China Construction Bank, and HSBC have no major operations in the United States. 

Top gainers and laggards in the Hang Seng Index

Biotech companies are some of the best-performing stocks in the Hang Seng Index this year. Sino Biopharmaceutical’s stock price has jumped by 130% this year. CSPC and Hansoh Pharmaceuticals have jumped by 108% and 106$, respectively. 

These biotech companies have surged this year, ending a four-year slump as investors cheered some major deals on Chinese biotech companies. For example, Pfizer reached a record $1.25 billion to license a cancer drug from 3SBio. Bristol-Myers Squibb then reached a deal to pay $11.5 billion for a drug that it licensed from China’s Biotheus. In a note, an analyst said:

“China biotech is no longer just an emerging story — unlike 10 years ago — it is now a disruptive force reshaping global drug innovation. The science is real, the economics are compelling, and the pipeline is starting to deliver.”

The other notable top gainers in the Hang Seng Index are Chow Tai Fook Jewellery, Kuaishou Technology, Wuxi AppTech, Wuxi Biologics, JD Health, and SMIC. All these stocks have jumped by over 80% this year. 

On the other hand, the top laggards in the Hang Seng Index are New Oriental, BYD Electronic, Meituan, Sinopharm Group, and Haier Smart Home. All these stocks have crashed by over 10% this year.

The post Hang Seng Index forecast and top gainers of 2025 revealed appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Here’s why the Rheinmetall share price will pop after earnings
next post
Nifty 50 Index forecast ahead of RBI interest rate decision

Related Posts

Falco Announces the Opening of Espace Falco and...

May 14, 2024

USD/CNY: why is the Chinese renminbi imploding?

January 9, 2025

USD/TRY forecast: to rise to 40 amid Fed...

December 28, 2024

Galan Increases Total Mineral Resource by 18% to...

March 28, 2024

ASX Retraction Statement

August 2, 2024

Remitly stock has multiple catalysts and could surge...

October 20, 2024

DXY surges: Is this the end of the...

May 13, 2025

Top 5 ASX Gold Stocks of 2024

June 2, 2024

Red alert: SCHD ETF just flashed a rare...

April 17, 2025

Honda to Establish C$15 Billion Electric Vehicle Value...

May 1, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • FBI raid on John Bolton’s home in Washington linked to classified documents

      August 25, 2025
    • Argentine senate deals blow to Milei’s austerity agenda with university budget boost

      August 25, 2025
    • Jackson Hole Symposium: what Powell said about economic effects of Trump’s tariffs

      August 25, 2025
    • At Jackson Hole, Fed Chair Powell signals possible cuts while warning of uncertainty

      August 25, 2025
    • Trump threatens to fire Fed Governor Lisa Cook amid mortgage fraud allegations

      August 25, 2025

    Categories

    • Business (3,753)
    • Investing (2,776)
    • Latest News (2,048)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved